Jonathan Welti

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

25h-index5.4kcitations182works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(79), Cancer, Lipids, and Metabolism(75), Hormonal and reproductive studies(34), Protein Degradation and Inhibitors(17), Eicosanoids and Hypertension Pharmacology(17)

Publications182 total

Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
iScience·2025Open Access
Figure 6 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S8 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Data from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 4 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 5 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 1 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S1 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 2 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S4 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S2 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Figure 3 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S10 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S5 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S3 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Tables S1-S13 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S9 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S7 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
Supplementary Figure S6 from NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
2025Open Access
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth
Clinical Cancer Research·2025· 6 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Johann S. de Bono(34), Adam Sharp(31), Antje Neeb(25), Stephen R. Plymate(23), Ruth Riisnaes(22), Amanda Swain(21), Ines Figueiredo(19), Suzanne Carreira(19), Bora Gürel(19), Mateus Crespo(18), Daniel Nava Rodrigues(16), Denisa Bogdan(16), Juan M. Jiménez‐Vacas(16), Susana Miranda(15), Lorenzo Buroni(13), Jan Rekowski(12), Jian Ning(11), Andrew R. Reynolds(10), Veronica Gil(10), Alec Paschalis(10)